Yoshida T, Shimizu K, Ushio Y, Hayakawa T, Mogami H, Nakata Y, Sakamoto Y
Gan To Kagaku Ryoho. 1984 Mar;11(3):458-63.
Experimental models of meningeal gliomatosis (MG) have been produced by intracisternal inoculation of C6 and 9L glioma cells into Wistar and Fisher 344 rats, respectively. Chemotherapy of these models and in vitro chemosensitivity assay for these cell lines were studied with ACNU, BCNU and VM-26. In vitro chemosensitivity assay revealed that 9L cells were sensitive to all of the anticancer drugs above, and that C6 cells were resistant to ACNU and BCNU, but not to VM-26. In vivo experiment, the survival time of the rats inoculated with 9L glioma cells (9LMG) was prolonged by both ACNU and BCNU but not by VM-26. None of these drugs were effective against the rats inoculated with C6 glioma cells (C6MG). It is concluded that the result of in vitro chemosensitivity assay is not always correlative with that of in vivo. This implies that an in vivo chemosensitivity assay system including MG models is indispensable in researching into chemotherapy of brain tumor.
分别通过向Wistar大鼠和Fisher 344大鼠脑池内接种C6和9L胶质瘤细胞,建立了脑膜胶质瘤病(MG)的实验模型。使用ACNU、BCNU和VM - 26对这些模型进行化疗,并对这些细胞系进行体外化学敏感性测定。体外化学敏感性测定显示,9L细胞对上述所有抗癌药物敏感,而C6细胞对ACNU和BCNU耐药,但对VM - 26不耐药。在体内实验中,接种9L胶质瘤细胞的大鼠(9LMG)的生存时间因ACNU和BCNU而延长,但不因VM - 26而延长。这些药物对接种C6胶质瘤细胞的大鼠(C6MG)均无效。结论是,体外化学敏感性测定的结果并不总是与体内结果相关。这意味着包括MG模型在内的体内化学敏感性测定系统在脑肿瘤化疗研究中是不可或缺的。